HOME Top Market Reports Veterinary/Animal Vaccines Market Product (Porcine, (Companion-Canine), (Livestock-Bovine), Poultry, Aquaculture), Diseases (Rabies, FMD, Swine Influenza, Strangles, Furunculous), Technology (DNA, Recombinant, Inactivated, Conjugate) - Forecast to 2021

Veterinary/Animal Vaccines Market Product (Porcine, (Companion-Canine), (Livestock-Bovine), Poultry, Aquaculture), Diseases (Rabies, FMD, Swine Influenza, Strangles, Furunculous), Technology (DNA, Recombinant, Inactivated, Conjugate) - Forecast to 2021

By: marketsandmarkets.com
Publishing Date: August 2016
Report Code: PH 3475

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global animal vaccines market is poised to reach USD 7.68 Billion by 2021 from USD 5.81 Billion in 2016, at a CAGR of 5.8% from 2016 to 2021. In this report, the global veterinary vaccines market is segmented on the basis of product, disease, technology, and region.

Based on product, the veterinary vaccine product market is categorized into companion animal, livestock, poultry, porcine, equine, aquaculture, and other animal vaccines. In animal vaccines market, companion animal vaccines form the fastest-growing segment, due to the increasing prevalence of zoonotic diseases in the human population and the growing number of pet owners worldwide.

On the basis of disease, the animal vaccines market is classified into companion animal, livestock, poultry, porcine, equine, aquaculture, and other diseases.

The technology segments covered in this report include live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines segment is estimated to account for the highest growth of the market in 2016, due to innovations in technology and increased public awareness about animal vaccination.

The growth of the veterinary vaccines market is propelled by the increase in livestock population and repeated breakouts of livestock diseases; increasing incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new vaccine types. Furthermore, market growth is supported by technological innovation, growing awareness on animal health in emerging economies, and increasing investment opportunities in emerging and immature markets. However, rising maintenance costs for the storage of vaccines and increasing prices of meat (which is promoting the adoption of vegetarian diets) are the key factors limiting the growth of animal vaccines market.

Key players operating in the animal vaccines market are Zoetis Inc. (Pfizer) (U.S.), Merck Animal Health (U.S.), Merial Inc. (France), Boehringer Ingelheim (Germany), Bayer Animal Health (Germany), Elanco Animal Health (U.S.), Ceva Animal Health (France), Heska Corporation (U.S.), and Virbac Inc. (France).

Target Audience:

  • Animal Vaccines Manufacturers
  • Animal Healthcare Product Manufacturers
  • Animal Vaccines Distributors and Wholesalers
  • Animal Welfare Associations
  • Veterinary Clinics and Care Centers
  • Various Research and Consulting Firms
  • Research Institutes
  • Contract Research Organizations (CROs)
  • Contract Manufacturing Organizations (CMOs)
  • Venture Capitalists

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

  • This study covers the global and regional market for animal vaccines—by product, disease, and technology

Particular

Scope

Region

  • North America
  • Europe
  • Asia
  • RoW

Historical Years

2014

Base Year

2015

Projected Year

2016

Forecast Period

2016–2021

Revenue Currency

USD

Market Segmentation

Veterinary Vaccines Market, by Product

  • Livestock Vaccines
    • Bovine Vaccines
    • Small Ruminant Animal Vaccines
  • Porcine Vaccines
  • Poultry Vaccines
  • Companion Animal Vaccines
    • Canine Vaccines
    • Feline Vaccines
  • Equine Vaccines
  • Aquaculture Vaccines
  • Other Animal Vaccines

Veterinary Vaccines Market, by Disease

  • Livestock Diseases
    • Bovine Disease
      • Foot-and-mouth Disease
      • Bovine Viral Diarrhea
      • Bovine Clostridial Diseases
      • Brucellosis
      • Infectious Bovine Rhinotracheitis
      • Others
    • Small Ruminant Animal Diseases
      • Small Ruminant Clostridial Diseases
      • Scabby Mouth Infection
      • Pneumonia and Septicemia
      • Pox Disease
      • Ovine Johne's Disease
      • Others
  • Porcine Diseases
    • Porcine Parvovirus
    • Porcine Reproductive Respiratory Syndrome (PRRS)
    • Porcine Circovirus II
    • Swine Influenza
    • Swine Pneumonia
    • Auzeszky's Disease
    • Others
  • Poultry Diseases
    • Infectious Bronchitis
    • Gumboro Disease
    • Avian Influenza
    • Coccidiosis
    • Marek’s Disease
    • Newcastle Disease
    • Mycoplasma
    • Others
  • Companion Animal Diseases
    • Canine Vaccines
      • Canine Distemper
      • Canine Parvovirus
      • Infectious Canine Hepatitis
      • Others
    • Feline Disease
      • Feline Rabies
      • Feline Panleukopenia
      • Feline Viral Rhinotracheitis
      • Feline Leukemia
      • Others
  • Equine Diseases
    • Equine Encephalomyelitis
    • Strangles
    • Equine Influenza
    • Tetanus
    • Equine Rhinopneumonitis
    • Others
  • Aquaculture Diseases
    • Vibriosis
    • Pasteurellosis
    • Furunculosis
    • Others
  • Other Animal Diseases

Animal Vaccines Market, by Technology

  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Conjugate Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • Subunit Vaccines

Veterinary Vaccines Market, by Region

  • North America
  • Europe
  • Asia
    • India
    • China
    • Thailand
    • South Korea
    • Rest of Asia (RoA)
  • RoW
    • Brazil
    • Other Countries

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Animal Vaccines Market Definition
    1.3 Animal Vaccines Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 23)
    2.1 Animal Vaccines Market Size Estimation
    2.2 Animal Vaccines Market Breakdown and Data Triangulation
           2.2.1 Key Data From Secondary Sources
           2.2.2 Key Data From Primary Sources
                    2.2.2.1 Key Industry Insights
    2.3 Assumptions

3 Executive Summary (Page No. - 30)
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 34)
    4.1 Veterinary Vaccines Market (2016-2021) to Grow at A Steady Rate
    4.2 Animal Vaccines Market, By Product
    4.3 Animal Vaccines Market, By Region
    4.4 Lifecycle Analysis, By Region

5 Market Overview (Page No. - 37)
    5.1 Introduction
    5.2 Animal Vaccines Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increase in Livestock Population and Repeated Breakouts of Livestock Diseases
                    5.2.1.2 Rise in Incidences of Zoonotic Diseases
                    5.2.1.3 Initiatives By Various Government Agencies, Animal Associations, and Leading Players
                    5.2.1.4 Introduction of New Types of Vaccines
           5.2.2 Restraints
                    5.2.2.1 Rising Costs for the Storage of Vaccines
                    5.2.2.2 Increasing Prices of Meat Promoting the Adoption of Vegetarian Diets
           5.2.3 Opportunities
                    5.2.3.1 Technological Innovation
                    5.2.3.2 Growing Awareness of Animal Health in Emerging Economies
           5.2.4 Challenge
                    5.2.4.1 Inadequate Surveillance and Reporting Systems

6 Veterinary Vaccines Market, By Product (Page No. - 44)
    6.1 Introduction
           6.1.1 Porcine Vaccines
           6.1.2 Poultry Vaccines
           6.1.3 Livestock Vaccines
           6.1.4 Companion Animal Vaccines
           6.1.5 Equine Vaccines
           6.1.6 Aquaculture Vaccines
           6.1.7 Other Animal Vaccines

7 Animal Vaccines Market, By Disease (Page No. - 47)
    7.1 Introduction
    7.2 Porcine Vaccines
    7.3 Poultry Vaccines
    7.4 Livestock Vaccines
           7.4.1 Bovine Vaccines
           7.4.2 Small Ruminant Vaccines
    7.5 Companion Animal Vaccines
           7.5.1 Canine Vaccines
           7.5.2 Feline Vaccines
    7.6 Equine Vaccines
    7.7 Aquaculture Vaccines

8 Veterinary Vaccines Market, By Technology (Page No. - 58)
    8.1 Introduction
    8.2 Live Attenuated Vaccines
    8.3 Inactivated Vaccines
    8.4 Toxoid Vaccines
    8.5 Recombinant Vaccines
    8.6 Conjugate Vaccines
    8.7 Subunit Vaccines
    8.8 DNA Vaccines

9 Veterinary Vaccines Market, By Region (Page No. - 69)
    9.1 Introduction
    9.2 Europe
    9.3 North America
    9.4 Asia
           9.4.1 China
           9.4.2 Thailand
                    9.4.2.1 Regulatory Landscape for Animal Vaccines in Thailand
           9.4.3 India
           9.4.4 South Korea
                    9.4.4.1 Regulatory Scenario
                               9.4.4.1.1 Regulatory Authorities: Veterinary Health and Safety
                    9.4.4.2 Related Regulations
                    9.4.4.3 Regulatory Requirements
                    9.4.4.4 Quality and Safety Control System
    9.5 Rest of the World (RoW)
           9.5.1 Brazil

10 Competitive Landscape (Page No. - 142)
     10.1 Introduction
     10.2 Strategic Analysis
     10.3 Animal Vaccines Market Share Analysis
     10.4 Veterinary Vaccines Market, Major Developments, By Product (2013–2015)
             10.4.1 Recent New Product Launches, Licenses, and Approvals By Market Player (2013–2016)
                        10.4.1.1 Zoetis (Pfizer)
                        10.4.1.2 Merck Animal Health
                        10.4.1.3 Boehringer Ingelheim Inc.
                        10.4.1.4 Ceva Animal Health
     10.5 Competitive Situation and Trends
             10.5.1 New Product Launches, Licenses, and Approvals
             10.5.2 Agreements, Partnerships, and Collaborations
             10.5.3 Acquisitions
             10.5.4 Expansions
             10.5.5 Other Developments

11 Company Profiles (Page No. - 152)
     11.1 Introduction
     11.2 Zoetis
     11.3 Merck Animal Health
     11.4 Merial Inc. (Sanofi)
     11.5 Boehringer Ingelheim
     11.6 Elanco Animal Health (Eli Lilly)
     11.7 Bayer Healthcare
     11.8 Ceva Animal Health
     11.9 Heska Corporation
     11.10 Vetoquinol
     11.11 Virbac Ltd.

12 Appendix (Page No. - 178)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Other Company Developments (2013–2016)
     12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.5 Introducing RT: Real-Time Market Intelligence
     12.6 Available Customizations
     12.7 Related Reports


List of Tables (144 Tables)

Table 1 Reported Zoonoses (2012-1016)
Table 2 Growing Incidence of Zoonotic Diseases to Drive the Veterinary Vaccines Market
Table 3 High Storage Cost of Vaccines to Restrain Market Growth
Table 4 Technological Advancements, A Key Area of Opportunity in the Market
Table 5 Inadequate Surveillance and Reporting Systems is A Major Challenge in the Market
Table 6 Animal Vaccines Market Size, By Product, 2014–2021 (USD Million)
Table 7 Porcine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 8 Poultry Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 9 Livestock Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 10 Bovine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 11 Small Ruminant Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 12 Companion Animal Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 13 Canine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 14 Feline Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 15 Equine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 16 Aquaculture Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 17 Veterinary Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 18 Live Attenuated Vaccines Market Size, By Animal Type, 2014–2021 (USD Million)
Table 19 Inactivated Vaccines Market Size, By Animal Type, 2014–2021 (USD Million)
Table 20 Toxoid Vaccines Market Size, By Animal Type, 2014–2021 (USD Million)
Table 21 Recombinant Vaccines Market Size, By Animal Type, 2014–2021 (USD Million)
Table 22 Conjugate Vaccines Market Size, By Animal Type, 2014–2021 (USD Million)
Table 23 Subunit Vaccines Market Size, By Animal Type, 2014–2021 (USD Million)
Table 24 DNA Vaccines Market Size, By Animal Type, 2014–2021 (USD Million)
Table 25 Animal Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 26 Europe: Animal Vaccines Market Size, By Product, 2014–2021 (USD Million)
Table 27 Europe: Porcine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 28 Europe: Porcine Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 29 Europe: Livestock Vaccines Market Size, By Category, 2014–2021 (USD Million)
Table 30 Europe: Bovine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 31 Europe: Small Ruminant Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 32 Europe: Livestock Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 33 Europe: Poultry Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 34 Europe: Poultry Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 35 Europe: Companion Animal Vaccines Market Size, By Category, 2014–2021 (USD Million)
Table 36 Europe: Canine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 37 Europe: Feline Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 38 Europe: Companion Animal Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 39 Europe: Equine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 40 Europe: Equine Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 41 Europe: Aquaculture Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 42 Europe: Aquaculture Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 43 North America: Veterinary Vaccines Market Size, By Product, 2014–2021 (USD Million)
Table 44 North America: Livestock Vaccines Market Size, By Category, 2014–2021 (USD Million)
Table 45 North America: Bovine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 46 North America: Small Ruminant Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 47 North America: Livestock Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 48 North America: Porcine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 49 North America: Porcine Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 50 North America: Poultry Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 51 North America: Poultry Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 52 North America: Companion Animal Vaccines Market Size, By Category, 2014–2021 (USD Million)
Table 53 North America: Canine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 54 North America: Feline Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 55 North America: Companion Animal Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 56 North America: Equine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 57 North America: Equine Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 58 North America: Aquaculture Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 59 North America: Aquaculture Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 60 China: Veterinary Vaccines Market Size, By Product, 2014–2021 (USD Million)
Table 61 China: Livestock Vaccines Market Size, By Category, 2014–2021 (USD Million)
Table 62 China: Bovine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 63 China: Small Ruminant Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 64 China: Livestock Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 65 China: Poultry Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 66 China: Poultry Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 67 China: Porcine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 68 China: Porcine Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 69 China: Companion Animal Vaccines Market Size, By Category, 2014–2021 (USD Million)
Table 70 China: Canine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 71 China: Feline Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 72 China: Companion Animal Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 73 China: Equine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 74 China: Equine Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 75 China: Aquaculture Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 76 China: Aquaculture Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 77 Thailand: Animal Vaccines Market Size, By Product, 2014–2021 (USD Million)
Table 78 Thailand: Porcine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 79 Thailand: Porcine Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 80 Thailand: Poultry Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 81 Thailand: Poultry Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 82 Thailand: Companion Animal Vaccines Market Size, By Category, 2014–2021 (USD Million)
Table 83 Thailand: Canine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 84 Thailand: Feline Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 85 Thailand: Companion Animal Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 86 Thailand: Livestock Animal Vaccines Market Size, By Category, 2014–2021 (USD Million)
Table 87 Thailand: Bovine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 88 Thailand: Small Ruminant Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 89 Thailand: Livestock Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 90 India: Animal Vaccines Market Size, By Product, 2014–2021 (USD Million)
Table 91 India: Livestock Vaccines Market Size, By Category, 2014–2021 (USD Million)
Table 92 India: Bovine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 93 India: Small Ruminant Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 94 India: Livestock Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 95 India: Poultry Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 96 India: Poultry Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 97 India: Porcine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 98 India: Porcine Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 99 India: Companion Animal Vaccines Market Size, By Category, 2014–2021 (USD Million)
Table 100 India: Canine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 101 India: Feline Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 102 India: Companion Animal Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 103 India: Equine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 104 India: Equine Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 105 India: Aquaculture Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 106 India: Aquaculture Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 107 South Korea: Animal Vaccines Market Size, By Product, 2014–2021 (USD Million)
Table 108 South Korea: Porcine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 109 South Korea: Porcine Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 110 South Korea: Bovine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 111 South Korea: Small Ruminant Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 112 South Korea: Livestock Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 113 South Korea: Poultry Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 114 South Korea: Poultry Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 115 South Korea: Canine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 116 South Korea: Feline Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 117 South Korea: Companion Animal Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 118 South Korea: Equine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 119 South Korea: Equine Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 120 South Korea: Aquaculture Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 121 South Korea: Aquaculture Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 122 Brazil: Veterinary Vaccines Market Size, By Product, 2014–2021 (USD Million)
Table 123 Brazil: Poultry Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 124 Brazil: Poultry Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 125 Brazil: Livestock Vaccines Market Size, By Category, 2014–2021 (USD Million)
Table 126 Brazil: Bovine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 127 Brazil: Small Ruminant Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 128 Brazil: Livestock Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 129 Brazil: Porcine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 130 Brazil: Porcine Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 131 Brazil: Companion Animal Vaccines Market Size, By Category, 2014–2021 (USD Million)
Table 132 Brazil: Canine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 133 Brazil: Feline Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 134 Brazil: Companion Animal Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 135 Brazil: Equine Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 136 Brazil: Equine Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 137 Brazil: Aquaculture Vaccines Market Size, By Disease, 2014–2021 (USD Million)
Table 138 Brazil: Aquaculture Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 139 Animal Vaccines Market, Major Developments (2013–2016)
Table 140 New Product Launches, Licenses, and Approvals, 2013–2016
Table 141 Agreements, Partnerships, and Collaborations, 2013–2016
Table 142 Acquisitions, 2013–2016
Table 143 Expansions, 2013–2016
Table 144 Other Developments, 2013–2016


List of Figures (73 Figures)

Figure 1 Research Design: Animal Vaccines Market
Figure 2 Animal Vaccines Market Size Estimation Approach
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Data Triangulation Methodology
Figure 5 Veterinary Vaccines Market, By Product, 2016 vs 2021 (USD Million)
Figure 6 Animal Vaccines Market, By Technology, 2016 vs 2021 (USD Million)
Figure 7 Porcine Vaccines Market, By Disease, 2016 vs 2021 (USD Million)
Figure 8 Canine Vaccines Market, By Disease, 2016 vs 2021 (USD Million)
Figure 9 Veterinary Vaccines Market, By Region, 2016 (USD Million)
Figure 10 Attractive Market Opportunities
Figure 11 Porcine Vaccines Segment to Account for the Largest Share of the Market in 2016
Figure 12 Asia Expected to Be the Fastest-Growing Region During the Forecast Period
Figure 13 Asian Market Showcases Lucrative Growth Opportunities During the Forecast Period
Figure 14 Increase in Livestock Population and Repeated Breakouts of Livestock Diseases to Boost Market Growth
Figure 15 Porcine Vaccines Segment is Expected to Account for the Largest Share of the Global Veterinary Vaccines Market in 2016
Figure 16 Porcine Circovirus Segment Projected to Grow at the Highest Rate in Porcine Vaccines Market, By 2021
Figure 17 Infectious Bronchitis Segment to Dominate the Poultry Vaccines Market in 2016
Figure 18 BVD Segment Projected to Grow at the Highest Rate in the Bovine Vaccines Market By 2021
Figure 19 Clostridial Diseases Segment to Dominate the Small Ruminant Vaccines Market in 2016
Figure 20 Canine Distemper Segment Projected to Grow at the Highest Rate in the Canine Vaccines Market By 2021
Figure 21 Feline Rabies Segment is Expected to Dominate the Feline Vaccines Market in 2016
Figure 22 Equine Rhinopneumonitis Segment Projected to Grow at the Highest Rate in the Equine Vaccines Market
Figure 23 Vibriosis to Dominate the Aquaculture Vaccines Market, By Disease, in 2016
Figure 24 Live Attenuated Vaccines Segment to Dominate the Animal Vaccines Market in 2016
Figure 25 Poultry Vaccines Segment is Expected to Dominate the Live Attenuated Vaccines Market in 2016
Figure 26 Companion Animal Vaccines Segment to Register Highest Growth Rate in the Inactivated Vaccines Market
Figure 27 Livestock Vaccines to Dominate the Toxoid Vaccines Market in 2016
Figure 28 Poultry Vaccines Segment to Grow at the Highest Rate in the Recombinant Vaccines Market
Figure 29 Porcine Vaccines to Dominate the Conjugate Vaccines Market in 2016
Figure 30 Livestock Vaccines to Grow at the Highest Rate in the Subunit Vaccines Market From 2016 to 2021
Figure 31 Porcine Vaccines Segment is Expected to Dominate the DNA Vaccines Market
Figure 32 Geographic Snapshot: Asia to Witness the Highest Growth in the Forecast Period
Figure 33 Asia, an Attractive Region for All Product Categories
Figure 34 Europe Will Continue to Lead the Global Veterinary Vaccines Market in the Forecast Period
Figure 35 The Demand for Animal Vaccines Will Be Driven By the Growing Production of Pig Meat in the Forecast Period
Figure 36 The Porcine Vaccines Segment is Expected to Account for the Largest Share of the European Veterinary Vaccines Market in 2016
Figure 37 Recombinant Vaccines Technology Will Be the Fastest-Growing Segment in the European Animal Vaccines Market During the Forecast Period
Figure 38 The Inactivated Vaccines Technology Segment Expected to Account for the Largest Share of the European Companion Animal Vaccines Market
Figure 39 Companion Animal Vaccines Will Be the Fastest-Growing Segment for North American Veterinary Vaccines Market in the Forecast Period
Figure 40 The Live Attenuated Vaccines Technology Segment is Expected to Account for the Largest Share of the North American Livestock Vaccines Market
Figure 41 Asia Market Snapshot: the Demand for Animal Vaccines Will Be Driven By Increasing Incidences of Zoonotic Diseases
Figure 42 The Livestock Vaccines Segment is Expected to Account for the Largest Share of the Veterinary Vaccines Market in China
Figure 43 Conjugate Vaccines Technology Will Be the Fastest-Growing Segment in the Asian Veterinary Vaccines Market During the Forecast Period
Figure 44 Steps Involved in the Marketing Authorization Approval of Veterinary Vaccines in Thailand
Figure 45 Registration Process
Figure 46 The Porcine Vaccines Segment is Expected to Account for the Largest Share of the Thailand Animal Vaccines Market in 2016
Figure 47 Recombinant Vaccines Technology Segment to Witness the Highest Growth in the Animal Vaccines Market in Thailand During the Forecast Period
Figure 48 Livestock Vaccines Segment is Expected to Account for the Largest Share of the Animal Vaccines Market in India
Figure 49 Conjugate Vaccines Technology Segment to Witness the Highest Growth in the Indian Livestock Vaccines Market
Figure 50 South Korean Veterinary Vaccines Market: Regulatory Authorities and Their Respective Roles
Figure 51 Porcine Vaccines Segment is Expected to Account for the Largest Share of the Animal Vaccines Market in South Korea
Figure 52 Inactivated Vaccines Technology Segment to Witness the Highest Growth in the South Korean Poultry Vaccines Market
Figure 53 Poultry Vaccines Segment Accounted for the Largest Share of the Veterinary Vaccines Market in Brazil
Figure 54 Inactivated Vaccines Technology Segment to Witness the Highest Growth in the Poultry Vaccines Market in Brazil
Figure 55 Key Developments in the Veterinary Vaccines Market, 2013-2016
Figure 56 Global Animal Vaccines Market Share, By Key Player, 2015
Figure 57 Animal Vaccines Market, Major Developments (2013–2016)
Figure 58 Zoetis (Pfizer) Focused on Porcine and Poultry Segment in the Last Few Years (2013-2016)
Figure 59 Merck Concentrated on the Aquaculture Segment (2013-2016)
Figure 60 Boehringer Ingelheim Mainly Concentrated on Equine and Porcine Segment (2013-2016)
Figure 61 Ceva Released New Products for the Poultry Segment (2013–2016)
Figure 62 Battle for Market Share: New Product Launches, Licenses, and Approvals—The Key Growth Strategy Adopted By Market Players Between 2013 & 2016
Figure 63 Geographic Revenue Mix of the Top Five Market Players
Figure 64 Zoetis: Company Snapshot
Figure 65 Merck Animal Health: Company Snapshot
Figure 66 Merial Inc. (Sanofi): Company Snapshot
Figure 67 Boehringer Ingelheim: Company Snapshot
Figure 68 Eli Lilly: Company Snapshot
Figure 69 Bayer Healthcare: Company Snapshot
Figure 70 Ceva Animal Health: Company Snapshot
Figure 71 Heska Corporation: Company Snapshot
Figure 72 Vetoquinol: Company Snapshot
Figure 73 Virbac Ltd.: Company Snapshot

The global animal vaccines market is poised to reach USD 7.68 Billion by 2021 from USD 5.81 Billion in 2016, at a CAGR of 5.8% from 2016 to 2021.

The increase in livestock population and repeated breakouts of livestock diseases; increasing incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new vaccine types are the major factors responsible for growth of the global animal vaccines market. In line with these growth factors, technological innovations such as DNA vaccines and growing awareness of animal health in emerging economies provide opportunities in this market. However, the rising costs of storage and maintenance of vaccines and the increasing price of meat, which promotes the adoption of vegetarian diets, are the major restraining factors in the veterinary vaccines market.

The animal vaccines market, by product, is segmented into companion animal, livestock, poultry, porcine, equine, aquaculture, and other animal vaccines. In this market, companion animal vaccines form the fastest-growing market segment. Its high growth is attributed to increasing awareness about vaccination, the increasing number of zoonotic diseases in human population, and the growth in the number of pets and pet owners.

The animal vaccines market, by technology, is categorized into inactivated vaccines, live attenuated vaccines, toxoid vaccines, conjugate vaccines, DNA vaccines, recombinant vaccines, and subunit vaccines. Live attenuated vaccines form the dominant technology segment in this market. The large share of this segment is mainly attributed to factors such as the increasing prevalence of diseases among porcine and poultry animals as well as the ease of administration and long-term immunity offered by these vaccines.

Animal Veterinary Vaccines Market

Geographically, the animal vaccines market is dominated by Europe, followed by North America. Asia is expected to grow at the highest CAGR during the forecast period. Technological innovations such as DNA vaccines, growing awareness of animal health in emerging economies, and increasing investment opportunities in emerging and immature markets are the major factors fueling the growth of the animal vaccines market in Asia.

Key players operating in the animal vaccines market are Zoetis Inc. (U.S.), Merck Animal Health (U.S.), Merial Inc. (Sanofi) (France), Boehringer Ingelheim (Germany), and Elanco Animal Health (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Pharmaceuticals Markets on KnowledgeStore
Request Demo